
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Check price for EmbodyOn Embody's site · partner link
Comparison · updated October 27, 2026
Start with Embody if a clinician finds a compounded injection appropriate and your priority is the lower published cash-pay entry.

Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Check price for EmbodyOn Embody's site · partner link
First month, then $298/mo
See prices and terms for HimsThese two prices are different kinds of bill, so read the line under each price before you compare them.
Embody pays us a commission through our links. Hims does not currently pay us for this comparison. That difference does not set scores or change the documented fit of either option. How we make money
This page compares Embody with Hims. Looking for Hers? Compare Embody vs Hers →
Start with Hims if you want an FDA-approved brand-name pill or pen and accept a separate required membership. Embody lists one-month compounded semaglutide at $79. Hims lists medication from $149, but its required membership brings the lowest path to $188 in month one and at least $298 monthly after that. These are different products and different billing structures, so the lowest headline alone should not decide.
Our pick for a lower-cost cash-pay injection entry
Embody publishes a $79 one-month compounded semaglutide plan with medication, clinical review and shipping included. It also offers compounded tirzepatide injections.
Treatment requires clinical approval. The medication is compounded and is not FDA approved. Longer plans lower the monthly equivalent but require more money up front.
Choose Hims for brand-name pills and pens
Hims lists FDA-approved brand-name oral and injectable options, including Wegovy pill and pen, through a familiar telehealth platform with ongoing app-based care.
Medication is billed separately from a required Weight Loss Membership. The lowest listed medication path totals $188 in month one and at least $298 monthly after that before product or dose increases.
Sources: Embody product catalogue · Hims medications, membership and pricing · FDA questions and answers on compounded drugs
| Embody | Hims | |
|---|---|---|
| Price | from $49/mo | $188First month, then $298/mo |
| Medicine | Compounded only | Brand-name only |
| Needle-free option | Not listed | Yes, a pill or other oral form |
| Insurance | BothNo insurance listed | |
| Consultation | Included | Included in required Weight Loss Membership ($39 first month, then $149/mo) |
| Shipping | Free | Not stated |
| Where it ships | 49 states plus DC, all except Louisiana | Not stated |
| Trustpilot | 3.8 / 5 across 10,100 reviews | Not tracked |
| BBB rating | D+ (not accredited) | Not tracked |
| Our score | 7.6/10 Good | Not scored Assessment unavailable |
| Assessment limits | Checked Oct 16, 2026; a rating claim didn't match Trustpilot. | No current assessment record is available for a score comparison. This does not establish the quality of care. |
These are published terms, not a quote for your prescription. How our links work.
Four published plan lengths for each injection. A sale advertised October 27 through December 1, 2026 cut the twelve-month prepaid amounts to $588 for semaglutide and $1,188 for tirzepatide; one-month plans stayed at $79 and $129.
Payments are normally non-refundable; a limited medical-disqualification exception applies.
The October 27–December 1, 2026 sale offers semaglutide at $49/month equivalent ($588 prepaid for twelve months) and tirzepatide at $99/month equivalent ($1,188 prepaid). One-month plans remain $79 and $129. The published terms say the rate stays fixed on the selected plan. Confirm the renewal amount and date before paying; these sale rates are not month-to-month bills.
We checked Embody's prices on October 27, 2026.Embody official pricing source
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
Want Embody on its own? Read our Embody GLP-1 review to see what you pay for semaglutide or tirzepatide and what customer reviews say, or check is Embody legit for its BBB, Trustpilot and FDA records.
The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 2.9 Trustpilot rating that lags peers.
Checked on hims.com/weight-loss October 17, 2026.
All-in floor for a $149 medication: $188 first month ($39 required Weight Loss Membership + $149 medication), then $298/mo ($149 membership + $149 medication); exact product and dose price varies
We checked Hims' prices on October 17, 2026.Hims official pricing source
Embody's catalogue lists one month of compounded semaglutide at $79 and one month of compounded tirzepatide at $129. Medication, clinical review and shipping are included. Its lowest monthly equivalents required prepayment: in a yearly-plan sale advertised October 27 through December 1, 2026, twelve months cost $588 for semaglutide, equal to $49 per month, or $1,188 for tirzepatide, equal to $99 per month. Confirm any current twelve-month price, the renewal amount and its date. Compare the total due today, not only the monthly-looking number.
Hims lists several medications from $149, including Wegovy pill, Foundayo and Ozempic pill. Its Weight Loss Membership is required and billed separately at $39 for month one, then $149 monthly. That makes a $149 medication path $188 initially and at least $298 in a later month if the same medication price applies. Wegovy and Ozempic pens start at $199 and Zepbound starts at $299 before membership, so the exact product and dose can raise the total.
Sources:Embody catalogue· Embody plan-by-plan pricing· Hims weight-loss prices
Embody's current catalogue focuses on compounded semaglutide and compounded tirzepatide injections. It does not currently list brand-name Wegovy, Zepbound, Ozempic or Mounjaro, and its former oral tirzepatide gum is no longer in the catalogue. Embody names four 503A pharmacy partners but does not say which pharmacy will fill a specific prescription before approval.
Hims' retail menu is built around brand-name options. It lists Wegovy as a daily pill and weekly pen, Foundayo as a pill, Ozempic as a pill and pen, Zepbound, and Mounjaro. Ozempic and Mounjaro are FDA approved for diabetes rather than weight loss, so any weight-loss use is an off-label clinical decision. Availability and eligibility still depend on the prescriber, product supply and the shopper's state.
The practical split is clear: Embody is the narrower compounded-injection route, while Hims offers more brand-name forms. Compounded products are not FDA approved and are not generic versions of approved brands. FDA does not review compounded drugs for safety, effectiveness or quality before marketing.
Sources:Embody current products· Hims current medication menu· FDA on compounded drugs
Hims is the relevant choice between these two if you want to discuss a pill. Its current menu includes brand-name oral options. Embody's current catalogue lists injections, so it is not the better fit for a needle-free shopper.
Do not choose a pill only because it avoids a needle. Ask which product and dose you may qualify for, whether the medicine is approved for your intended use, what the complete recurring bill is, and how dosing or side effects may differ. Our Wegovy pill guide owns the broader oral-medication question and tracks the current options separately.
Sources:Hims oral and injectable options· Current Wegovy pill guide
Embody says its plan includes an online assessment, clinician review through OpenLoop Health, coaching and shipping. A clinician decides whether treatment is appropriate after checkout. The individual clinician and dispensing pharmacy are not named before signup.
Hims separates care from medication on the bill. Its required membership includes access to a care team, in-app messaging and tracking, dosage adjustments when clinically appropriate, and other support described on its weight-loss page. A membership payment does not guarantee a prescription, and medication remains a separate charge.
Choose the care model you will actually use. A lower bundled price has more value if you are comfortable with Embody's narrower injection program. Hims' higher continuing bill may be worth considering if its brand-name menu, pill access and established app experience solve a need Embody does not.
Sources:Embody program and included care· Hims membership and care features· Independent Embody review
For Embody, confirm the exact medication, total charged today, plan length, refill timing and which pharmacy will fill the prescription. Payments are normally non-refundable. Embody's policy provides a limited refund for unused services when its provider determines medical disqualification, after deducting services already provided. Other cancellations stop future renewal and must reach support at least 72 hours before the next billing date.
For Hims, confirm the membership charge and medication charge as separate lines, the product and dose, state availability, shipping if any, and the next billing date. Hims says the first membership fee is non-refundable and asks customers to cancel at least two days before renewal. Medication is not refundable once shipped.
For either service, save the checkout terms and confirmation. If you are changing providers, do not cancel an existing prescription path until the receiving clinician has reviewed your treatment and you understand the next refill plan.
Sources:Embody refund and cancellation policy· Hims program and billing information
Strengths
More to watch for
Strengths
More to watch for
Compounded medicines are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are sold. Read the FDA's explanation of the risks.
No. Embody's current catalogue lists compounded semaglutide and tirzepatide injections.
Not on the lowest published complete cash-pay examples.
Both comparison records are cash-pay paths and neither bills insurance for the programs described here.
Embody:prices checked October 27, 2026, score evidence assessed October 16, 2026.Read our Embody review
Hims:prices checked October 17, 2026, score evidence assessed September 3, 2026.Hims pricing and sources
We score on a published methodology, and partnership never changes a score or a fact here.
Before you sign up, read our trust check: is Embody legit.
Embody reviewHims prices and sourcesAll comparisonsFind your match